Please use this identifier to cite or link to this item: https://doi.org/10.1053/jlts.2002.34148
Title: Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin
Authors: Lee, K.-H. 
Wendon, J.
Lee, M.
Da Costa, M. 
Lim, S.-G. 
Tan, K.-C.
Issue Date: 2002
Source: Lee, K.-H., Wendon, J., Lee, M., Da Costa, M., Lim, S.-G., Tan, K.-C. (2002). Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin. Liver Transplantation 8 (7) : 591-593. ScholarBank@NUS Repository. https://doi.org/10.1053/jlts.2002.34148
Abstract: Extracorporeal albumin dialysis with the molecular adsorbent recirculating system (MARS) machine is a new supportive intervention for patients with liver failure. It removes bilirubin and other albumin-bound toxins from the patient and has been shown by preliminary studies of liver failure patients to be beneficial. Our study examines the ability of predialysis molar ratio of bilirubin to albumin to predict the decrease of bilirubin by MARS. We had 5 patients and results from 29 treatments. The results showed a significant correlation between the predialysis molar ratio of bilirubin (total and conjugated) to albumin to the reduction in bilirubin (total and conjugated): R2 = 0.27 and 0.62 respectively, P < .005 for both. There was no significant correlation with the predialysis molar ratio of unconjugated bilirubin to albumin to the reduction in unconjugated bilirubin. The ratio of change in total bilirubin (μmol/L) to the predialysis molar ratio of total bilirubin to albumin and the ratio of change in conjugated bilirubin (μmol/L) to the predialysis molar ratio of conjugated bilirubin to albumin were 6.2 (± 4.2) and 10.8 (± 4.3), respectively (mean (± SD)). The results enable us to predict the likely reduction in bilirubin (especially conjugated) after each MARS treatment and also suggest to us that albumin infusion before MARS treatment may reduce the efficacy of bilirubin removal. Whether this ratio applies to other albumin-bound toxins remains open for investigation.
Source Title: Liver Transplantation
URI: http://scholarbank.nus.edu.sg/handle/10635/131243
ISSN: 15276465
DOI: 10.1053/jlts.2002.34148
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

WEB OF SCIENCETM
Citations

25
checked on Nov 16, 2017

Page view(s)

9
checked on Jan 21, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.